Thrombin-cleavable chimeric proteins
CA 2463772 C · Owner: Calmel, Claire · Inventors: Calmel, Claire; Marque, Pierre-Emmanuel; Louvain, Virginie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to chimeric proteins comprising an artificial sequence for cleavage by thrombin, in which the activation peptide is fibrinopeptide A. Preferably, said chimeric proteins are derived from the zymogen of a serine protease such as PC or FX, by replacing the activation peptide of said zymogen with fibrinopeptide A, or a portion thereof comprising at least amino acids , P10 to P1 of said fibrinopeptide.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 18, 2002 and granted July 29, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 18, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 18, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.